This Marijuana Stock's Sales Are Shrinking: Should We Care? 0 06.12.2016 06:04 «FOX Business» (foxbusiness.com) GW Pharmaceuticals' revenue tumbled in its fiscal fourth quarter, but investors might be better off focusing on the company's future opportunity for sales growth rather than its past. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
